UBS Keeps Buy Rating on Johnson & Johnson with $320 Target Price
UBS analyst Michael Yee has maintained Johnson & Johnson (JNJ.US) with a buy rating and kept its target price at $320.
This decision was made after reviewing TipRanks data, which shows that the analyst has a success rate of 47.0% and an average return of 2.5% over the past year.
The information presented is not an investment recommendation and is intended for informational purposes only.